193 related articles for article (PubMed ID: 26129710)
1. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway.
Hu Z; Xie L
Mol Med Rep; 2015 Sep; 12(3):4634-4639. PubMed ID: 26129710
[TBL] [Abstract][Full Text] [Related]
2. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
Bi QJ; Men XJ; Han R; Li GL
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/β-catenin and P53 signaling pathways.
Chen HQ; Zhao J; Li Y; Huang YJ; Chen DJ; He LX; Wang LQ; Zheng CF; Wang J; Cao J; Shu WQ; Liu JY; Liu WB
Environ Pollut; 2019 Sep; 252(Pt A):216-226. PubMed ID: 31151060
[TBL] [Abstract][Full Text] [Related]
4. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.
Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY
Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of tumor-suppressor gene LHX6 in cancer: a systematic review.
Nathalia E; Theardy MS; Elvira S; Rosellinny G; Liyanto AS; Utama MP; Sumarpo A
Rom J Intern Med; 2018 Sep; 56(3):135-142. PubMed ID: 29533904
[TBL] [Abstract][Full Text] [Related]
6. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer.
Tan Z; Zheng H; Liu X; Zhang W; Zhu J; Wu G; Cao L; Song J; Wu S; Song L; Li J
Oncotarget; 2016 Apr; 7(17):24076-87. PubMed ID: 26992223
[TBL] [Abstract][Full Text] [Related]
8. Lhx6 and Lhx8: cell fate regulators and beyond.
Zhou C; Yang G; Chen M; He L; Xiang L; Ricupero C; Mao JJ; Ling J
FASEB J; 2015 Oct; 29(10):4083-91. PubMed ID: 26148970
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-224 inhibits proliferation and migration of breast cancer cells by down-regulating Fizzled 5 expression.
Liu F; Liu Y; Shen J; Zhang G; Han J
Oncotarget; 2016 Aug; 7(31):49130-49142. PubMed ID: 27323393
[TBL] [Abstract][Full Text] [Related]
10. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Wu H; Marcus A; Leyland-Jones B; Dey N
Oncotarget; 2016 Jul; 7(28):43124-43149. PubMed ID: 27281609
[TBL] [Abstract][Full Text] [Related]
11. Lhx6 regulates canonical Wnt signaling to control the fate of mesenchymal progenitor cells during mouse molar root patterning.
He J; Jing J; Feng J; Han X; Yuan Y; Guo T; Pei F; Ma Y; Cho C; Ho TV; Chai Y
PLoS Genet; 2021 Feb; 17(2):e1009320. PubMed ID: 33596195
[TBL] [Abstract][Full Text] [Related]
12. Downregulated GBX2 gene suppresses proliferation, invasion and angiogenesis of breast cancer cells through inhibiting the Wnt/β-catenin signaling pathway.
Fang Y; Yuan Y; Zhang LL; Lu JW; Feng JF; Hu SN
Cancer Biomark; 2018; 23(3):405-418. PubMed ID: 30223390
[TBL] [Abstract][Full Text] [Related]
13. Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer.
Abudurexiti Y; Gu Z; Chakma K; Hata T; Motoi F; Unno M; Horii A; Fukushige S
Biochem Biophys Res Commun; 2020 Jun; 526(3):626-632. PubMed ID: 32248980
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-1 down-regulates proliferation and migration of breast cancer stem cells by inhibiting the Wnt/β-catenin pathway.
Liu T; Hu K; Zhao Z; Chen G; Ou X; Zhang H; Zhang X; Wei X; Wang D; Cui M; Liu C
Oncotarget; 2015 Dec; 6(39):41638-49. PubMed ID: 26497855
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
16. KDM3B-ETF1 fusion gene downregulates LMO2 via the WNT/β-catenin signaling pathway, promoting metastasis of invasive ductal carcinoma.
Hu A; Hong F; Li D; Xie Q; Chen K; Zhu L; He H
Cancer Gene Ther; 2022 Feb; 29(2):215-224. PubMed ID: 33828234
[TBL] [Abstract][Full Text] [Related]
17. Suppression of the proliferation and invasion of breast cancer cells by ST7L occurs through inhibition of activation of Wnt/GSK-3β/β-catenin signalling.
Wang H; Sun L; Jiang J; Yu S; Zhou Q
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):119-126. PubMed ID: 31429477
[TBL] [Abstract][Full Text] [Related]
18. HSulf-1 inhibits cell proliferation and invasion in human gastric cancer.
Li J; Mo ML; Chen Z; Yang J; Li QS; Wang DJ; Zhang H; Ye YJ; Li HL; Zhang F; Zhou HM
Cancer Sci; 2011 Oct; 102(10):1815-21. PubMed ID: 21722266
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway.
Yang F; Xiao Z; Zhang S
Int J Mol Med; 2018 Dec; 42(6):3355-3363. PubMed ID: 30272253
[TBL] [Abstract][Full Text] [Related]
20. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
